溶瘤病毒
肺癌
医学
免疫疗法
癌症
癌症治疗
斯科普斯
肿瘤科
肺癌的治疗
重症监护医学
内科学
免疫学
梅德林
生物
生物化学
作者
Hamza Sakhi,Mohadeseh Arabi,Amir Ghaemi,Abolfazl Movafagh,Mojgan Sheikhpour
出处
期刊:Immunotherapy
[Future Medicine]
日期:2024-02-01
卷期号:16 (2): 75-97
被引量:1
标识
DOI:10.2217/imt-2023-0124
摘要
Lung cancer has a high morbidity rate worldwide due to its resistance to therapy. So new treatment options are needed to improve the outcomes of lung cancer treatment. This study aimed to evaluate the effectiveness of oncolytic viruses (OVs) as a new type of cancer treatment. In this study, 158 articles from PubMed and Scopus from 1994 to 2022 were reviewed on the effectiveness of OVs in the treatment of lung cancer. The oncolytic properties of eight categories of OVs and their interactions with treatment options were investigated. OVs can be applied as a promising immunotherapy option, as they are reproduced selectively in different types of cancer cells, cause tumor cell lysis and trigger efficient immune responses.
科研通智能强力驱动
Strongly Powered by AbleSci AI